Literature DB >> 4100685

C1r, subunit of the first complement component: purification, properties, and assay based on its linking role.

M M De Bracco, R M Stroud.   

Abstract

A method to obtain C1r, a subunit of the first complement component, in a highly purified state has been described for the first time. The stepwise method starts with a neutral euglobulin precipitation, after diethylaminoethyl- and carboxymethyl-cellulose chromatography and a final preparative polyacrylamide electrophoresis step. Such C1r preparations are devoid of C1q and C1s activities and show only one protein band on analytic polyacrylamide electrophoresis. Rabbits injected with this preparation produced antisera showing only one precipitation band. The stability of C1r activity was determined under different conditions, and C1r was found to be labile at 37 degrees C, pH 7-8 and low ionic strength. The electrophoretic mobility of purified C1r is that of a beta-globulin on disc acrylamide electrophoresis and on agarose electrophoresis at pH 8.6. Its molecular weight as estimated by sephadex chromatography is 168,100.A sensitive hemolytic assay based on the property of C1r to link C1s to C1q and thereby to generate macromolecular C[unk]1 is described. The number of C[unk]1 molecules generated is stoichiometrically related to the concentration of C1r for a fixed C1q and C1s concentration provided that the titration is carried out below the plateau zone. Macromolecular C1 can be separated from free C1s as the former is cell bound. This method of purification and assay should allow the development of monospecific antisera and further chemical study of C1r.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4100685      PMCID: PMC291998          DOI: 10.1172/JCI106555

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  Concerning the mechanism of complement action. I. Inhibition of complement activity by diisopropyl fluophosphate.

Authors:  E L BECKER
Journal:  J Immunol       Date:  1956-12       Impact factor: 5.422

3.  The relationship of the hemolytic activity of active C'1s to its TAMe esterase action: a new method of purification and assay.

Authors:  K Nagaki; R M Stroud
Journal:  J Immunol       Date:  1969-02       Impact factor: 5.422

4.  Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.

Authors:  R A Nelson; J Jensen; I Gigli; N Tamura
Journal:  Immunochemistry       Date:  1966-03

5.  The influence of calcium ions on the inactivation of human complement and its components by plasmin.

Authors:  I H LEPOW; L PILLEMER; O D RATNOFF
Journal:  J Exp Med       Date:  1953-09       Impact factor: 14.307

6.  The conversion of C'IS to C'1 esterase by plasmin and trypsin.

Authors:  O D Ratnoff; G B Naff
Journal:  J Exp Med       Date:  1967-02-01       Impact factor: 14.307

7.  Fluid phase destruction of C2hu by C1hu. II. Unmasking by C4ihu of C1hu specificity for C2hu.

Authors:  I Gigli; K F Austen
Journal:  J Exp Med       Date:  1969-10-01       Impact factor: 14.307

8.  Deficiency of C1r in human serum. Effects on the structure and function of macromolecular C1.

Authors:  R J Pickering; G B Naff; R M Stroud; R A Good; H Gewurz
Journal:  J Exp Med       Date:  1970-04-01       Impact factor: 14.307

9.  THE MACROMOLECULAR NATURE OF THE FIRST COMPONENT OF HUMAN COMPLEMENT.

Authors:  G B NAFF; J PENSKY; I H LEPOW
Journal:  J Exp Med       Date:  1964-04-01       Impact factor: 14.307

10.  The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor.

Authors:  O D Ratnoff; J Pensky; D Ogston; G B Naff
Journal:  J Exp Med       Date:  1969-02-01       Impact factor: 14.307

View more
  7 in total

1.  Specific antisera to Clr. Quantitation of Clr in normal and pathological human sera.

Authors:  M M de Bracco; C L Christian; R M Stroud
Journal:  Clin Exp Immunol       Date:  1974-03       Impact factor: 4.330

2.  Studies on the first component of complement (C1) and the inhibitor of C1 esterase in rheumatoid synovial fluids.

Authors:  M M De Bracco; R M Stroud; C L Christian
Journal:  Clin Exp Immunol       Date:  1972-06       Impact factor: 4.330

3.  The structure and enzymic activities of the C1r and C1s subcomponents of C1, the first component of human serum complement.

Authors:  R B Sim; R R Porter; K B Reid; I Gigli
Journal:  Biochem J       Date:  1977-05-01       Impact factor: 3.857

4.  A novel leupeptin-sensitive serine endopeptidase present in normal and malignant rat mammary tissues.

Authors:  I Eto; M D Bandy
Journal:  Mol Cell Biochem       Date:  1990-04-18       Impact factor: 3.396

5.  The catalytic chain of human complement subcomponent C1r. Purification and N-terminal amino acid sequences of the major cyanogen bromide-cleavage fragments.

Authors:  G J Arlaud; J Gagnon; R R Porter
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

6.  C1r deficiency: an inborn error associated with cutaneous and renal disease.

Authors:  N K Day; H Geiger; R Stroud; M DeBracco; B Mancaido; D Windhorst; R A Good
Journal:  J Clin Invest       Date:  1972-05       Impact factor: 14.808

7.  Familial C1q deficiency associated with renal and cutaneous disease.

Authors:  F Leyva-Cobián; I Moneo; F Mampaso; M Sánchez-Bayle; J L Ecija; A Bootello
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.